ライフサイエンスコーパス: phosphate-buffered

1 trodeposition of cobalt oxide materials from phosphate-buffered electrolyte solutions.

2 ion from 20 to 120 nM in high ionic strength phosphate-buffered fluoride (PBF) buffer, yielding a lim

3 of one fixative and buffer type (10% neutral phosphate-buffered formalin, pH 7) for FFPE tissue acros

4 LAD (100 microg/mouse intraperitoneally), or phosphate buffered saline (100 microl/mouse intraperiton

5 controlling the concentration of Dulbecco's phosphate buffered saline (DPBS) electrolyte, the double

6 ml x 15 ml) (n = 12) or mock challenged with phosphate buffered saline (n = 6).

7 The models were exposed to phosphate buffered saline (negative control), triethylen

8 acy increased to a higher level (~100%) when phosphate buffered saline (PBS containing 137 mM NaCl) w

9 r injections (50 microl/injection) of either phosphate buffered saline (PBS) (n = 9), human synoviocy

10 bilized antibodies on the ZnO surface in (i) phosphate buffered saline (PBS) and (ii) human serum.

11 Detection of cTnT in phosphate buffered saline (PBS) and human serum (HS) buf

12 anging from ~10(5) to 3.2 x 10(7) CFUs/mL in phosphate buffered saline (PBS) and peritoneal dialysis

13 entrations of Immunoglobulin G (IgG) in both phosphate buffered saline (PBS) and spiked in E. coli ce

14 e lateral motion with synovial fluid (SF) or phosphate buffered saline (PBS) as lubricant.

15 hest Q approximately 9300 in the bio-ambient phosphate buffered saline (PBS) as well as highest sensi

16 either Freund's incomplete adjuvant (IFA) or phosphate buffered saline (PBS) at monthly intervals.

17 rene (d(8)-PS) and SiO(2) model surfaces and phosphate buffered saline (PBS) at pH 7.4.

18 ns, and was found to be slowly degradable in phosphate buffered saline (PBS) but more rapidly degrade

19 ound to contain higher TPC, TFC and TCC than phosphate buffered saline (PBS) extracts for all the fru

20 particle loaded gels can release timolol in phosphate buffered saline (PBS) for about a month at roo

21 g was induced in one eye with glutaraldehyde/phosphate buffered saline (PBS) immersion while the othe

22 Incubation of the coated sensors in phosphate buffered saline (PBS) led to a monotonic incre

23 t between phospholipid bilayer membranes and phosphate buffered saline (PBS) medium (DMW,PBS) for 19

24 DF-1) versus a bolus application of SDF-1 in phosphate buffered saline (PBS) on wound healing was eva

25 re injected subcutaneously with bleomycin or phosphate buffered saline (PBS) once daily for 28 days.

26 tions of physiologic ionic strength, such as phosphate buffered saline (PBS) or 150 mM KCl.

27 nanoparticles was enhanced compared to DMSO/phosphate buffered saline (PBS) or albumin/PBS solutions

28 pended inside a flowing medium that contains phosphate buffered saline (PBS) or whole blood.

29 lly captured and detected HIV-1 in serum and phosphate buffered saline (PBS) samples with viral loads

30 lin analog and the other delivered a control phosphate buffered saline (PBS) solution with no insulin

31 mplification at room temperature in 30min in phosphate buffered saline (PBS) solution.

32 ther with fibrocytes, dermal fibroblasts, or phosphate buffered saline (PBS) through tail vein inject

33 Prolonged hydration in phosphate buffered saline (PBS) was found to significant

34 When phosphate buffered saline (PBS) was present in the chann

35 , we explore the effect of concentration for phosphate buffered saline (PBS), a typical ionic medium

36 anotubes were found not only to be stable to phosphate buffered saline (PBS), serum, and a variety of

37 The films were shown to be stable in phosphate buffered saline (PBS).

38 ch resonances show high Q in the bio-ambient phosphate buffered saline (PBS).

39 ol mice were similarly injected with sterile phosphate buffered saline (PBS).

40 a control vector with no insert (AxCANI), or phosphate buffered saline (PBS).

41 that received either aqueous DSP solution or phosphate buffered saline (PBS).

42 lized on a gold film in both air and flowing phosphate buffered saline (PBS).

43 performed in physiological buffers, such as phosphate buffered saline (PBS).

44 R) at a diffusion-controlled rate in aerated phosphate buffered saline (PBS).

45 ere performed at 37 degrees C in rat plasma, phosphate buffered saline (PBS, pH 7.4) and PB (pH 7.4).

46 release of 23% and 47% bound lactic acid in phosphate buffered saline (PBS, pH7.4) and acetate buffe

47 raarticular injections (50 mul/injection) of phosphate buffered saline (PBS; n = 14 rats) and human s

48 and their critical micelle concentrations in phosphate buffered saline (pH 7.4) are </=85 microg/mL.

49 ately as Hg sources in washed cell assays in phosphate buffered saline (pH 7.4), we report how cell-m

50 d as OP(*OH)) from both Fe(II) and Cu(II) in phosphate buffered saline (pH 7.40) containing ascorbic

51 in vivo compared to in vitro using agitated phosphate buffered saline +0.02% Tween 80 pH7.4, includi

52 The reaction was efficient in phosphate buffered saline and a wide range of biological

53 We have calibrated the sensor using phosphate buffered saline and demonstrated trace detecti

54 tion limits of 1 pM and 10 pM of thrombin in phosphate buffered saline and mimic serum solution, resp

55 at 10 and 30 pg/mL level was demonstrated in phosphate buffered saline and serum, respectively.

56 and interlaboratory measurements, samples of phosphate buffered saline and urine, spiked with differe

57 nose-6-Phosphate (29 animals), or 100 mul of phosphate buffered saline as a placebo control (29 anima

58 approximately 5fg/ml for assays conducted in phosphate buffered saline buffer (PBS) and approximately

59 nhancer of viral infection fibrils formed in phosphate buffered saline keep evolving after the initia

60 In phosphate buffered saline medium the actual lipophilicit

61 Control nonischemic limbs were injected with phosphate buffered saline or remained noninjected.

62 ysis using a short gel-filtration column and phosphate buffered saline solution as the mobile phase.

63 d detection of E. coli in buffered solution (phosphate buffered saline solution).

64 , Neq)> decreased from approximately 0.24 in phosphate buffered saline to 0.12 in 3,300 mug/ml HA and

65 th a 15% solution of saponin and washed with phosphate buffered saline to release intact parasites.

66 after the surgical induction of OA, LUB:1 or phosphate buffered saline vehicle was administered by in

67 Control animals were treated with a phosphate buffered saline vehicle while the other group

68 unction studies, recombinant IL-7 or control phosphate buffered saline was injected intraperitoneally

69 SEB dissolved in phosphate buffered saline was resolved to levels as low

70 LV-1h153 (1 x 10(7) plaque-forming units) or phosphate buffered saline was tested in an orthotopic mu

71 Given time, most of the assemblies in phosphate buffered saline will turn into elongated thin

72 ol virus without insert, or control vehicle (phosphate buffered saline) intraarticularly before arthr

73 in a complex matrix (bovine serum albumin in phosphate buffered saline) is also demonstrated through

74 Competition experiments (in 68% DMSO/phosphate buffered saline) using 1 equiv of N-phenethyl-

75 obtained compared to result obtained in PBS (phosphate buffered saline).

76 .0078mg/ml of T24 (Grade III) cell lysate in phosphate buffered saline, artificial urine and human ur

77 cross-sections of brushite cylinders aged in Phosphate Buffered Saline, Foetal Bovine Serum, Dulbecco

78 xhibited excellent analytical performance in phosphate buffered saline, including a NO sensitivity of

79 ry and the differential pulse voltammetry in phosphate buffered saline, pH = 7.0.

80 In the phosphate buffered saline-treated animals, human skin al

81 te in HCG-treated mice compared with that in phosphate buffered saline-treated mice.

82 3-treated P. gingivalis-infected mice versus phosphate buffered saline-treated P. gingivalis-infected

83 tection limit of 500 muM in water and 1mM in phosphate buffered saline.

84 via a sandwich immunoassay for human IgG in phosphate buffered saline.

85 tuses fixed overnight in 4% paraformaldehyde/phosphate buffered saline.

86 25 head and neck squamous carcinoma cells in phosphate buffered saline.

87 specific and little non-specific binding in phosphate buffered saline.

88 Outflow facility for phosphate-buffered saline (0.0027 +/- 0.00036 muL/min/mm

89 em of acellular agarose disks and dextran in phosphate-buffered saline (3 and 70 kDa).

90 . cenocepacia strain BC7 suspended in either phosphate-buffered saline (BC7/PBS) or P. aeruginosa alg

91 e injected with BM-MSCs, AT-MSCs, or vehicle-phosphate-buffered saline (Control) 2 weeks post-defect

92 l suspension of liposomes coated with either phosphate-buffered saline (control) or clodronate (a mac

93 s, eyes received 5 microL of either Dulbecco phosphate-buffered saline (D-PBS), 10 microM D9R, or 100

94 bacterial endotoxin contained in Dulbecco's phosphate-buffered saline (DPBS), a cohesive OVD, and a

95 c adenocarcinoma cell line Pan02 (cancer) or phosphate-buffered saline (healthy).

96 cells at room temperature or 4 degrees C in phosphate-buffered saline (labeling efficiency range, 13

97 imits ranging from 1 to 40 pg in 6 muL of 1x phosphate-buffered saline (PBS) (0.2-6 ng/mL) were achie

98 In the presence of 5 mM glucose in phosphate-buffered saline (PBS) (50 mM phosphate buffer

99 n conjunctival fibroblasts were incubated in phosphate-buffered saline (PBS) (control), MMC (0.2 mg/m

100 d in 50 mg/mL TCN solution (experimental) or phosphate-buffered saline (PBS) (control).

101 aryngeally aspirated 200 ug of WTC-PM(53) or phosphate-buffered saline (PBS) (controls).

102 of transduced human MSCs suspended in either phosphate-buffered saline (PBS) (n = 4) or matrigel (n =

103 subunit (CTB) or heat-labile toxin (LTB), or phosphate-buffered saline (PBS) alone and then challenge

104 y with buffers A, B, and C, or separately by phosphate-buffered saline (PBS) alone.

105 n of the brain with cold or room temperature phosphate-buffered saline (PBS) also caused significant

106 d -25 degrees C for at least 3 days by using phosphate-buffered saline (PBS) and cysteine/methionine-

107 determination of prohibited substances from phosphate-buffered saline (PBS) and human urine using Fe

108 The detection curves were obtained in phosphate-buffered saline (PBS) and in undiluted artific

109 ts/mouse), lipopolysaccharide (2 microg), or phosphate-buffered saline (PBS) and sacrificed mice 24 h

110 niae were treated intravenously with PFCE or phosphate-buffered saline (PBS) and then managed in eith

111 tal recoveries obtained for all compounds in phosphate-buffered saline (PBS) and urine samples owing

112 bats with one of four vaccine treatments or phosphate-buffered saline (PBS) as a control and challen

113 HDP-cyclic-CDV was suspended in phosphate-buffered saline (PBS) at 37 degrees C and form

114 es for the detection of nitric oxide (NO) in phosphate-buffered saline (PBS) at pH 7.4.

115 were injected with cultured mast cells or 1x phosphate-buffered saline (PBS) before collecting serum,

116 to ovalbumin (OVA-psigma1), psigma1 only, or phosphate-buffered saline (PBS) before oral challenge wi

117 pSHEV-1 triple mutant, wild-type pSHEV-3, or phosphate-buffered saline (PBS) buffer (n = 10).

118 CA15-3 detection was first characterized in phosphate-buffered saline (PBS) buffer and in fetal calf

119 at generated by bare carbon nanotube yarn in phosphate-buffered saline (PBS) buffer.

120 Hydrolysis in pH 5.5 Mes and pH 7.2 phosphate-buffered saline (PBS) buffers was similar, but

121 Phosphate-buffered saline (PBS) containing celecoxib-PLG

122 In phosphate-buffered saline (PBS) containing EDTA, the apo

123 -2-infected guinea pigs compared to those of phosphate-buffered saline (PBS) control-vaccinated anima

124 ignificant reduction of diarrhea compared to phosphate-buffered saline (PBS) controls (PE = 84.1%; P

125 ear in WT-infected mice did not differ from phosphate-buffered saline (PBS) controls or mice infecte

126 A plus Vaxfectin i.m. or 100 mug of DNA plus phosphate-buffered saline (PBS) i.m. using a needleless

127 in the presence of succinate, fumarate, and phosphate-buffered saline (PBS) in different cell models

128 Finally, experiments with phosphate-buffered saline (PBS) indicate that the films

129 rfusion of Adv.cmv.L-CPT1 (L-CPT1, n=15) vs. phosphate-buffered saline (PBS) infusion (PBS, n=7) or e

130 technique for cell-free virus elution using phosphate-buffered saline (PBS) may provide an alternati

131 p was intravenously injected either with 2mL phosphate-buffered saline (PBS) or 3million hUTC in PBS

132 animals used as controls were injected with phosphate-buffered saline (PBS) or GBV-B, respectively.

133 olar lavage fluids from mice inoculated with phosphate-buffered saline (PBS) or S. aureus were deplet

134 ue-Dawley rats, 2 microg rhTSG-6 in 5-microL phosphate-buffered saline (PBS) or the same volume of on

135 th a S-OIV clinical isolate concentration in phosphate-buffered saline (PBS) over a range of 18-1.8 x

136 The LK14 peptide, adsorbed from a pH 7.4 phosphate-buffered saline (PBS) solution, displayed very

137 rythrocytes at 37 degrees C for up to 24h in phosphate-buffered saline (PBS) supplemented with 0 to 5

138 lity to recover DNA from Brucella species in phosphate-buffered saline (PBS) suspension and from spik

139 plification was achieved through dilution of phosphate-buffered saline (PBS) to tune Cdl to dominate

140 ll crowd and then extracted with ~0.5 muL of phosphate-buffered saline (PBS) via pipet immediately af

141 Biliverdin (40 mg/kg) or phosphate-buffered saline (PBS) was administered either

142 As an internal control, phosphate-buffered saline (PBS) was similarly injected o

143 to 400 mg/dL or 0.10-10.34 mmol/L in 100 mM phosphate-buffered saline (PBS) without significant inte

144 Inhibition of alpha-toxin by phosphate-buffered saline (PBS), 0.1% methyl-beta-cyclod

145 (PPSV23; Merck, Whitehouse Station, NJ), or phosphate-buffered saline (PBS), before corneal infectio

146 hat C. neoformans grown with IgM, not IgG or phosphate-buffered saline (PBS), had decreased expressio

147 reserved in diverse sample matrices, namely, phosphate-buffered saline (PBS), Middlebrook 7H9 medium

148 ibodies (mAbs) and ADCs, such as nonvolatile phosphate-buffered saline (PBS), should be replaced befo

149 tion (BDL) for 14 days and were treated with phosphate-buffered saline (PBS), UDCA, all-trans retinoi

150 were attained for all the studied probes in phosphate-buffered saline (PBS), urine, and whole blood.

151 ere surface-inoculated with P. aeruginosa in phosphate-buffered saline (PBS), while sterile PBS was u

152 Here we report that a phosphate-buffered saline (PBS)-based nucleofection meth

153 lae were found in their spleens, unlike with phosphate-buffered saline (PBS)-dosed mice, and vaccinat

154 e exhibited a dermal architecture similar to phosphate-buffered saline (PBS)-injected control and nor

155 as 2.5-fold higher than in the contralateral phosphate-buffered saline (PBS)-injected eye (n = 6 rats

156 ferritin Ab-functionalized microparticles in phosphate-buffered saline (PBS).

157 tions of VIPhyb (peptidic VIP-antagonist) or phosphate-buffered saline (PBS).

158 r 50 mg/kg per week), nontarget (NT) ASO, or phosphate-buffered saline (PBS).

159 ol mice were similarly injected with sterile phosphate-buffered saline (PBS).

160 oneal injection of either 5 g/kg of rhTrx or phosphate-buffered saline (PBS).

161 1% apoEdp, 1% trifluorothymidine (TFT), and phosphate-buffered saline (PBS).

162 ne injections of lipopolysaccharide (LPS) or phosphate-buffered saline (PBS).

163 Control mice received phosphate-buffered saline (PBS).

164 injection of 1 million human fibroblasts in phosphate-buffered saline (PBS); group 2, intravenous in

165 iRNA-21 in the range from 10 pM to 100 nM in phosphate-buffered saline (PBS); the limit of detection

166 Phosphate-buffered saline (PBS, control, n=7) or 3x10(6)

167 obiota in two frequently used batch systems: phosphate-buffered saline (PBS, oligotrophic) and basal

168 ted 24 hours after intravitreal injection of phosphate-buffered saline (PBS, vehicle) or PBS + ouabai

169 Control animals received phosphate-buffered saline (PBS; n = 5 to 7).

170 reported affinity for a cryptophane host in phosphate-buffered saline (pH 7.2).

171 Four groups were studied: sham and SCI plus phosphate-buffered saline (SCI + PBS), human embryonic k

172 usion of either human recombinant decorin or phosphate-buffered saline (vehicle).

173 Myocardial retention of cells suspended in phosphate-buffered saline 1 h after delivery was 17.6 +/

174 BALB/c mice received LAIV or phosphate-buffered saline 1 or 7 days before or during p

175 d pigs (n = 130) in one of four groups (PRCV/phosphate-buffered saline [PBS] [n = 41], PRCV/DEX [n =

176 RMG (but not in those vaccinated with REG or phosphate-buffered saline [PBS]) after homologous or het

177 antibody pair detects PA(83) down to 1 nM in phosphate-buffered saline and 5 nM in human serum, which

178 d 2-[(131) I] exhibit good stability in both phosphate-buffered saline and blood serum.

179 t IL-22 or anti-IL-22 neutralizing antibody; phosphate-buffered saline and IgG served as respective c

180 ntly enhanced analytical performance in both phosphate-buffered saline and plasma (6-20x improvement

181 4.5 and 7.2, (2) physiologic salt solutions (phosphate-buffered saline and saline) commonly used for

182 ated mice compared to those in animals given phosphate-buffered saline and then infected with the bac

183 thod is approximately 1 IU/mL (2 nM) in both phosphate-buffered saline and urine samples, and only 0.

184 pyridine analogues were more soluble in both phosphate-buffered saline and water.

185 lated with herpes simplex virus 1 (HSV-1) or phosphate-buffered saline as a control.

186 determinations were lower in both saline and phosphate-buffered saline as compared to vaginal fluid m

187 dies of Abeta(1-40) amyloid fibrils grown in phosphate-buffered saline at 37 degrees C under unstirre

188 Release studies were conducted in phosphate-buffered saline at 37 degrees C with continuou

189 formed soluble aggregates upon dilution into phosphate-buffered saline at 37 degrees C.

190 ells were formed into pellets and covered in phosphate-buffered saline at room temperature for 56 h.

191 of 0.5-10 mL containing 5-1000 ppb TNT in a phosphate-buffered saline buffer were preconcentrated in

192 ration of TT30 were unaffected by citrate or phosphate-buffered saline buffers and indicate an elonga

193 paB and 12 serum cytokines (p < or = .05 vs. phosphate-buffered saline challenge, except for interleu

194 et for 12 weeks, then administered rIL-19 or phosphate-buffered saline concomitant with Western diet

195 the HIV-1 RNA level in cervicovaginal fluid, phosphate-buffered saline containing 10 mM LiCl was used

196 An investigation of drug release kinetics in phosphate-buffered saline containing Tween 80 led us to

197 Afterwards, 5 x 10(5) CSCs (n = 30) or phosphate-buffered saline control (n = 15) was injected

198 dose of 20 mg/kg orally twice daily (n=7) or phosphate-buffered saline control (n=6) orally for 7 day

199 herent on a quartz substrate in a deuterated phosphate-buffered saline environment at room temperatur

200 The aerosol particles were then dispersed in phosphate-buffered saline for cytotoxicity and senescenc

201 TNNB1-LNP), scrambled sequence (Scr-LNP), or phosphate-buffered saline for multiple cycles.

202 estoration of urothelial layers, whereas the phosphate-buffered saline group had ongoing regeneration

203 were compared with those of single agents or phosphate-buffered saline in a Raji2R-xenograft model.

204 formed different complexes in serum than in phosphate-buffered saline in terms of both size and affi

205 human amniotic mesenchymal stromal cells or phosphate-buffered saline infused intracerebroventricula

206 mucosa between the molars; and 6) group I-V: phosphate-buffered saline injected into the palatal muco

207 thogenic Escherichia coli (MG1655 strain) or phosphate-buffered saline into the urethra of mice led t

208 data with theoretical results suggests that phosphate-buffered saline is a good solvent for Q8 and Q

209 Mouse IgG diluted in phosphate-buffered saline is used as model target antige

210 assembly by injection from THF solution into phosphate-buffered saline led to unilamellar, monodisper

211 evels (i.e., 6-240 mg/dL) were quantified in phosphate-buffered saline medium using multivariate anal

212 e injected i.p. with 50 or 250 mg/kg APAP or phosphate-buffered saline on gestation day 12.5; nonpreg

213 individuals by the oral route, mice were fed phosphate-buffered saline or 10(6)M. canettii mycobacter

214 tal fat-derived stem/stromal cells in 50 muL phosphate-buffered saline or 50 muL phosphate-buffered s

215 dium was truncated by switching the cells to phosphate-buffered saline or by the addition of antibiot

216 Phosphate-buffered saline or iPSC-w/o-c-Myc was then int

217 anti-GXM died earlier than mice treated with phosphate-buffered saline or irrelevant isotype-matched

218 (OVA) at days 0 and 12, received intranasal phosphate-buffered saline or OVA challenges at days 24,

219 sensitized by intraperitoneal injections of phosphate-buffered saline or ovalbumin (OVA) at days 0 a

220 Formaldehyde, diluted in either phosphate-buffered saline or phosphate buffer, has been

221 addressed in murine airways challenged with phosphate-buffered saline or Pseudomonas aeruginosa.

222 e, which were challenged with OVA peptide or phosphate-buffered saline or remained untreated.

223 ed with either bone marrow-derived MSCs or a phosphate-buffered saline placebo via direct intraventri

224 of BM cells and intramyocardial injection of phosphate-buffered saline rarely induced arrhythmias.

225 ily dissociated from the graft surface after phosphate-buffered saline rinsing.

226 properties of the water-soluble chlorins in phosphate-buffered saline solution (pH 7.4) at room temp

227 Mice that received phosphate-buffered saline solution only were included as

228 ide, and the ECL of the 1a film was found in phosphate-buffered saline solution with TPrA.

229 versibility of PRET upon the introduction of phosphate-buffered saline to the channel.

230 regulator PG490-88 (MRx-108; 0.75 mg/kg) or phosphate-buffered saline was administered preventilatio

231 tacept (CTLA4-Ig), etanercept (anti-TNF), or phosphate-buffered saline were given to NMRI mice intrav

232 o hundred thousand cells suspended in 20 muL phosphate-buffered saline were mixed with 200 muL Matrig

233 hat does not contain a transgene (Ad312) and phosphate-buffered saline were used as controls.

234 er-resolution microscopy was demonstrated in phosphate-buffered saline without any reducing or oxidiz

235 Cys, a synthetic ligand of TLR2, or vehicle (phosphate-buffered saline) 24 h prior to Staphylococcus

236 ion of infection compared to mock-immunized (phosphate-buffered saline) animals.

237 g/kg bodyweight intraperitoneal) or vehicle (phosphate-buffered saline) as control.

238 iae (1,500 colony-forming units) or vehicle (phosphate-buffered saline) at 3 or 60 days post-injury.

239 domized to a single IV injection of vehicle (phosphate-buffered saline) or suppressor of site IQ elec

240 wth and prolonged median survival from 13 d (phosphate-buffered saline) to 20 and 29 d for DAR2 and D

241 In vehicle (phosphate-buffered saline)-pretreated mice, nonapoptotic

242 Median survival for the groups treated with phosphate-buffered saline, 6 MBq (213)Bi-IMP288, 12 MBq

243 omers enables robust cross-linking in water, phosphate-buffered saline, and cell culture medium to af

244 be delivered in a commercial moisturizer or phosphate-buffered saline, and do not require barrier di

245 temically administered (64)CuCl2 (74 MBq) or phosphate-buffered saline, and tumor sizes were monitore

246 d stability of these probes were assessed in phosphate-buffered saline, cell culture medium, rat seru

247 emotherapy alone, RF hyperthermia alone, and phosphate-buffered saline, combination therapy with RF h

248 emotherapy alone, RF hyperthermia alone, and phosphate-buffered saline, combination therapy with RF h

249 ation of 760+/-160 pM (120+/-25 ngml(-1)) in phosphate-buffered saline, falling to 2.5+/-0.7 nM (380+

250 othelial cells, n = 4) or control treatment (phosphate-buffered saline, n = 4) by means of imaging-gu

251 nction 2 weeks after transplant (hCPC versus phosphate-buffered saline, P<0.03).

252 itro radiotracer stability was determined in phosphate-buffered saline, pH 7.4, and in challenge stud

253 99% radiochemical purity and were stable in phosphate-buffered saline, pH 7.4, for 24 h.

254 (22.1 +/- 18.6% and 5.3 +/- 3.1%, for FG and phosphate-buffered saline, respectively).

255 of HCV(VLDF), compared with that mixed with phosphate-buffered saline, showing extracellular assembl

256 eceived an intracerebral injection of either phosphate-buffered saline, the neurotoxin saporin (SAP),

257 lutathione-S-transferase (rGST)-adjuvant and phosphate-buffered saline-adjuvant served as nonvaccinat

258 s (6.1 +/- 0.5 %ID/cm(3)) when compared with phosphate-buffered saline-challenged animals (4.6 +/- 0.

259 tumor growth compared with mice treated with phosphate-buffered saline-containing liposomes (P<0.001)

260 atment groups were compared with age-matched phosphate-buffered saline-injected control transgenic an

261 led animals receiving intravenous vehicle or phosphate-buffered saline-instilled animals receiving me

262 with parstatin compared to their respective phosphate-buffered saline-treated controls.

263 improve muscle regeneration, laminin-111 or phosphate-buffered saline-treated laminin-alpha2-deficie

264 antibody-treated animals lived, whereas 3/8 phosphate-buffered saline-treated mice died.

265 face atherosclerosis was noted compared with phosphate-buffered saline-treated mice.

266 D45(+) cells in the prostates of E. coli- or phosphate-buffered saline-treated mice.

267 m 6TG-treated primary recipients relative to phosphate-buffered saline-treated recipients.

268 rly but increased later compared to those in phosphate-buffered saline-treated, PRCV-infected pigs, c

269 eached as low as 3.5x10(1)CFUmL(-1) in 0.01M phosphate-buffered saline.

270 erapy only, (c) RF hyperthermia only, or (d) phosphate-buffered saline.

271 h; sham controls received an equal volume of phosphate-buffered saline.

272 ce treated with a scrambled-sequence PPMO or phosphate-buffered saline.

273 in all groups were agitated for 3 minutes in phosphate-buffered saline.

274 , nonpretargeted (177)Lu-IMP288 (60 MBq), or phosphate-buffered saline.

275 /kg) for 3 weeks, while 10 controls received phosphate-buffered saline.

276 n 50 muL phosphate-buffered saline or 50 muL phosphate-buffered saline.

277 axane (25 mg/kg every other day, 3 doses) or phosphate-buffered saline.

278 /d), AG490, a JAK2 inhibitor (5 mg/kg/d), or phosphate-buffered saline.

279 d incubated with either 75 microM ammonia or phosphate-buffered saline.

280 incubating celecoxib and melanin in isotonic phosphate-buffered saline.

281 to the Con A concentration up to 10(-7) M in phosphate-buffered saline.

282 ith OVA, compared with controls treated with phosphate-buffered saline.

283 for culture of mammalian and yeast cells and phosphate-buffered saline.

284 and 0.69 V, as a result of the diffusion of phosphate-buffered saline.

285 omic shift of 115 nm on changing from THF to phosphate-buffered saline.

286 py alone, (c) RF hyperthermia alone, and (d) phosphate-buffered saline.

287 were intratracheally instilled with sterile phosphate-buffered saline.

288 q of (212)Pb-daratumumab instead of 11 d for phosphate-buffered saline.

289 littermates received intraperitoneal nIgM or phosphate-buffered saline/bovine serum albumin/immunoglo

290 alone (200 million cells, n=5), or placebo (phosphate-buffered saline; n=5) was injected into the in

291 56days in various media: pH5.5, 6.5, and 7.4 phosphate buffered-saline (PBS) containing 0.02% Tween 8

292 The O2 concentrations in air-saturated phosphate-buffered salt solutions were monitored by meas

293 In phosphate-buffered solution, cis-4-fluoroproline is more

294 immune deficiency virus) antibodies (Ab) in phosphate buffered solutions (PBS).

295 imaging (MFI) during freeze-thaw cycling in phosphate buffered solutions.

296 nt (kexp) found in both 1 mM NaHCO3 and 1 mM phosphate-buffered solutions suggested that OH radical w

297 re structure is compromised by mild aging in phosphate-buffered solutions, initiating mesopore collap

298 ate) (ABTS) and self-decay of ferrate(VI) in phosphate-buffered solutions.

299 on of an inert indium tin oxide electrode in phosphate-buffered water containing cobalt (II) ions.

300 and ferric chloride addition in borate- and phosphate-buffered waters showed that phosphate could se